UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2020
(Commission File No. 001-37518)
Benitec Biopharma Limited
(Translation of registrant’s name into English)
Level 14, 114 William St, Melbourne, VIC, 3000
Australia
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1):
Yes ☐ No ☒
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7):
Yes ☐ No ☒
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No ☒
Exhibit |
|
Description |
99.1
|
|
Appendix 3Y |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
|
|
Benitec Biopharma Limited |
|
|
|
By: |
/s/ Megan Boston |
Name: |
Megan Boston |
Title: |
Executive Director |
Date: March 30, 2020
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Benitec Biopharma Limited |
ABN 64 068 943 662
|
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director |
Peter Damian Francis |
Date of last notice |
4 June 2018 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Direct or indirect interest |
Direct and indirect |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
|
Francis Family Superannuation Fund |
Date of change |
27 March 2020 |
No. of securities held prior to change |
Direct 90,000 fully paid ordinary shares (FPOS)
Indirect 546,261 FPOS |
Class |
As above |
Number acquired |
875,000 FPOS |
Number disposed |
None |
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation
|
$27,157.55 |
+ See chapter 19 for defined terms.
01/01/2011Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
Direct 90,000 FPOS
Indirect 1,421,261 FPOS |
|
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
On-market purchase |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract |
Not applicable. |
Nature of interest
|
|
Name of registered holder (if issued securities)
|
|
Date of change |
|
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
|
|
Interest acquired |
|
Interest disposed |
|
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
|
|
Interest after change |
|
Part 3 – +Closed period
+ See chapter 19 for defined terms.
Appendix 3Y Page 201/01/2011
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 |
Appendix 3Y Page 3 |